| 09:00 | Registration |
| 09:30 | Welcome Frank Vermassen, UZ Gent, Belgium |
| 09:35 | Session 1: Controversies in the management of lung cancer Chairs: Veerle Surmont, UZ Gent & Christian Rolfo, UZA |
| 09:35 | Hadron therapy in lung cancer Wilfried Deneve, UZ Gent, Belgium |
| 10:00 | Debate: EGFR-TKI’s going wild Pro: Treatment for all comers Annelies Janssens, UZ Antwerp, Belgium Con: TAILORed treatment Marina Garassino, Istituto Tumori-Milano, Italy |
| 10:30 | Smoking cessation in patients with (lung) cancer: does it matter? Wanda de Kanter, NKI, Amsterdam, The Netherlands |
| 11:00 | Break |
| 11:30 | Session 2: Cancer immunotherapy: back to the future? Chairs: Birgitta Hiddinga, UZA & Thomas Malfait, UZ Gent |
| 11:30 | Checkpoint immunotherapy with monoclonal antibodies Mary O’Brien, Royal Marsden Hospital, London, UK |
| 12:00 | Cellular immunotherapy Karim Vermaelen, UZ Gent, Belgium |
| 12:25 | Clinical experience with vaccination against MUC-1 glycoprotein Charles Butts, Department of Oncology, University of Alberta, Alberta, Canada |
| 12:55 | Adjourn Jan van Meerbeeck, UZA, Belgium |
| 13:00 | Buffet |
We are delighted to invite you to our 10th Thoracic Oncology Winter symposium on January 18, 2014.
This jubilee edition of our annual symposium offers a unique opportunity to meet (inter)national experts in thoracic oncology and discuss challenging controversies and promising innovations in the field, e.g immuno- and hadrontherapy.
Pencil the date in your brand new 2014 agenda, don’t miss this experience and take the opportunity to visit and shop in Ghent after the meeting. There are some great sales opportunities…
We look forward to meet you in Ghent,
Prof. Dr . J. van Meerbeeck, Coördinator Thoraxoncologie, MOCA UZA
Prof. Dr . V. Surmont, Coördinator LONG
